PortViewPortView
Rockwell Medical logo

Rockwell Medical (RMTI) Stock Analysis

NASDAQHealthcareDrug Manufacturers - Specialty & Generic

$8.13+1.06%
1-year price historyRange $5.19 – $18.00
52-week range$8.13
$4.89$18.80

What Rockwell Medical does

Rockwell Medical, Inc., together with its associated companies, operates as a biopharmaceutical firm specializing in treatments for chronic and end-stage kidney disease. The company provides a range of therapies and products aimed at addressing iron deficiency and supporting hemodialysis procedures, serving markets both within the United States and internationally. A key offering includes its Triferic line (Triferic Dialysate and Triferic AVNU), an innovative iron replacement therapy. This therapy is designed to replenish iron and maintain healthy hemoglobin levels in dialysis patients, notably without increasing existing iron stores. Beyond iron management, Rockwell Medical manufactures, sells, and distributes a comprehensive range of hemodialysis concentrates. These include various acid concentrates such as CitraPure (citric), Dri-Sate (dry), and RenalPure (liquid), alongside a dry acid concentrate mixer, and powder bicarbonate concentrates like RenalPure and SteriLyte. These crucial products are vital for sustaining life in dialysis patients by facilitating the removal of toxins and the replacement of essential nutrients in their bloodstream. The company further supplies ancillary items critical for hemodialysis procedures. This extensive catalog comprises blood tubing, fistula needles, dialyzers, pharmaceuticals, specialized component kits, dressings, cleaning agents, filtration salts, and other necessary provisions utilized by hemodialysis providers. Looking to the future, Rockwell Medical is actively developing additional therapeutic candidates. These include treatments for hospitalized individuals suffering from acute heart failure, as well as solutions for home infusion therapy, enabling patients to receive intravenous medications in a home setting. The company primarily serves medium and small-sized dialysis chains, as well as independent dialysis centers. Established in 1996, Rockwell Medical, Inc. maintains its corporate headquarters in Wixom, Michigan.

Key metrics

Market cap
$32.09M
P/E (TTM)
-6.07
EPS (TTM)
$-1.34
Beta
1.62
Dividend yield
0.00%
Revenue / share
$17.53
50-day avg
$6.82
200-day avg
$8.48
52-week high
$18.80
52-week low
$4.89
CEO
Mark Strobeck

ETFs linked to RMTI

Broad-market and Healthcare sector ETFs an investor holding Rockwell Medical is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how RMTI fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze RMTI in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for Rockwell Medical?
Rockwell Medical trades under the ticker RMTI on NASDAQ.
Which exchange is RMTI listed on?
RMTI is listed on NASDAQ.
What sector does Rockwell Medical operate in?
Rockwell Medical is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
How can PortView help analyze RMTI in a portfolio?
PortView shows RMTI's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.